Hjem › Graft-versus-host-sygdom › Ohio
Graft-versus-host-sygdom kliniske forsøg i Ohio
7 studier for Graft-versus-host-sygdom søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
RekruttererObservationsstudie
Alder 18 til 70 · Kvinder · Opdateret 29. sep. 2026 · NCT06649201Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
- The Ohio State University, Columbus
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT06450925A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 2
Alder 2 og opefter · Alle køn · Opdateret 16. jun. 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. maj 2026 · NCT06615050Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. apr. 2026 · NCT07356245Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Ohio State University Medical Center, Columbus
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 25. mar. 2026 · NCT03533816A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Cleveland Clinic, Cleveland
- The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.